What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Cancer
Her scientific interests lie mostly in Endocrinology, Internal medicine, Polycystic ovary, Insulin resistance and Insulin.
Her work on Body mass index, Anovulation and Exercise physiology as part of general Endocrinology research is frequently linked to Context, thereby connecting diverse disciplines of science.
Her Internal medicine research includes elements of Eating disorders and Stressor.
Her specific area of interest is Polycystic ovary, where Evanthia Diamanti-Kandarakis studies Hyperandrogenism.
Her studies in Insulin resistance integrate themes in fields like Metformin, Type 2 diabetes and Endocrine system.
Her Insulin study incorporates themes from Sex hormone-binding globulin and Ovary.
Her most cited work include:
- Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement (2578 citations)
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline (1429 citations)
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report (1201 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Internal medicine, Endocrinology, Polycystic ovary, Insulin resistance and Insulin.
Evanthia Diamanti-Kandarakis frequently studies issues relating to Diabetes mellitus and Internal medicine.
Her biological study spans a wide range of topics, including Metformin and Bioinformatics.
In her study, Genetic heterogeneity and Ovarian Disorder is inextricably linked to Type 2 diabetes, which falls within the broad field of Insulin resistance.
Her Insulin study combines topics in areas such as Sex hormone-binding globulin and Receptor.
Evanthia Diamanti-Kandarakis focuses mostly in the field of Anovulation, narrowing it down to matters related to hirsutism and, in some cases, Gynecology.
She most often published in these fields:
- Internal medicine (73.84%)
- Endocrinology (68.60%)
- Polycystic ovary (62.21%)
What were the highlights of her more recent work (between 2016-2021)?
- Polycystic ovary (62.21%)
- Internal medicine (73.84%)
- Endocrinology (68.60%)
In recent papers she was focusing on the following fields of study:
Evanthia Diamanti-Kandarakis mainly investigates Polycystic ovary, Internal medicine, Endocrinology, Bioinformatics and Insulin resistance.
Her Polycystic ovary study combines topics from a wide range of disciplines, such as Ovary, Gonadotropin secretion and Infertility.
Her research on Endocrinology frequently connects to adjacent areas such as Inflammation.
Her study in Bioinformatics is interdisciplinary in nature, drawing from both Emotional stress, Disease, Metabolic Stress and Endocrine system.
Insulin covers Evanthia Diamanti-Kandarakis research in Insulin resistance.
Her Hyperandrogenism research is multidisciplinary, incorporating elements of Aromatase, Pediatrics and Congenital adrenal hyperplasia.
Between 2016 and 2021, her most popular works were:
- Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease. (35 citations)
- MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview. (35 citations)
- Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond. (21 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Her primary areas of study are Bioinformatics, Disease, Polycystic ovary, Insulin resistance and Endocrine system.
Her work carried out in the field of Bioinformatics brings together such families of science as Oxidative stress, Hypoxia, Pathogenesis, Glycation and Proinflammatory cytokine.
Her Disease research incorporates elements of Regulator, Longevity and Diet therapy.
Her biological study focuses on Polycystic ovary syndrome.
The concepts of her Insulin resistance study are interwoven with issues in Metformin, Aromatase inhibitor and Ovary.
Her Endocrine system research is multidisciplinary, relying on both Adipose tissue, Metabolic syndrome, Epigenetics and Fatty liver.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
